Detalles de la búsqueda
1.
Ivacaftor in Infants Aged 4 to <12 Months with Cystic Fibrosis and a Gating Mutation. Results of a Two-Part Phase 3 Clinical Trial.
Am J Respir Crit Care Med
; 203(5): 585-593, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33023304
2.
Phase 1 Study to Assess the Safety and Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Subjects Without Cystic Fibrosis With Moderate Hepatic Impairment.
Eur J Drug Metab Pharmacokinet
; 47(6): 817-825, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36036885
3.
A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic fibrosis homozygous for F508del or heterozygous for the F508del-CFTR mutation and a residual function mutation.
J Cyst Fibros
; 20(1): 68-77, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32967799
4.
Correction to: Physiologically Based Pharmacokinetic Modeling of CFTR Modulation in People with Cystic Fibrosis Transitioning from Mono or Dual Regimens to Triple-Combination Elexacaftor/Tezacaftor/Ivacaftor.
Pulm Ther
; 6(2): 287, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32856286
5.
Physiologically Based Pharmacokinetic Modeling of CFTR Modulation in People with Cystic Fibrosis Transitioning from Mono or Dual Regimens to Triple-Combination Elexacaftor/Tezacaftor/Ivacaftor.
Pulm Ther
; 6(2): 275-286, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32734574
6.
Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor.
J Cyst Fibros
; 16(1): 41-44, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27773592
7.
Liver-to-plasma vaniprevir (MK-7009) concentration ratios in HCV-infected patients.
Antivir Ther
; 20(8): 843-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25849338
8.
Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: safety, antiviral activity, resistance, and pharmacokinetics.
Antiviral Res
; 99(3): 214-20, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23747481
Resultados
1 -
8
de 8
1
Próxima >
>>